{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T13:39:48Z","timestamp":1791293988542,"version":"4.1.0"},"reference-count":44,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"20","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1097\/md.0000000000000523","type":"journal-article","created":{"date-parts":[[2015,5,21]],"date-time":"2015-05-21T18:17:13Z","timestamp":1432232233000},"page":"e523","source":"Crossref","is-referenced-by-count":58,"title":["In Antisynthetase Syndrome, ACPA Are Associated With Severe and Erosive Arthritis"],"prefix":"10.1097","volume":"94","author":[{"given":"Alain","family":"Meyer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Lefevre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Bierry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aur\u00e9lie","family":"Duval","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9bastien","family":"Ottaviani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Tournadre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benoit","family":"Le Goff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Messer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne Laure","family":"Buchdahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"De Bandt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Deligny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthieu","family":"Dubois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Coquerelle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00e9raldine","family":"Falgarone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren\u00e9-Marc","family":"Flipo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexis","family":"Mathian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Geny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahir","family":"Amoura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Benveniste","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Hachulla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Sibilia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baptiste","family":"Hervier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-1-20210226","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1136\/ard.2006.051391","article-title":"Diagnostic and predictive value of anti-cyclic citrullinated protein antibodies in rheumatoid arthritis: a systematic literature review.","volume":"65","author":"Avouac","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"R2-1-20210226","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1002\/art.27584","article-title":"2010 Rheumatoid arthritis classification criteria: an American College of RheumatologyEuropean League Against Rheumatism collaborative initiative.","volume":"62","author":"Aletaha","year":"2010","journal-title":"Arthritis Rheum"},{"key":"R3-1-20210226","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1136\/ard.2003.016808","article-title":"Anti-CCP antibody test predicts the disease course during 3 years in early rheumatoid arthritis (the Swedish TIRA project).","volume":"63","author":"Kastbom","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"R4-1-20210226","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1136\/ard.62.2.120","article-title":"Anticitrullinated proteinpeptide antibody assays in early rheumatoid arthritis for predicting five year radiographic damage.","volume":"62","author":"Meyer","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"R5-1-20210226","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1136\/ard.2007.084715","article-title":"Association of rheumatoid factor and anti-cyclic citrullinated peptide positivity, but not carriage of shared epitope or PTPN22 susceptibility variants, with anti-tumour necrosis factor response in rheumatoid arthritis.","volume":"68","author":"Potter","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"R6-1-20210226","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.3899\/jrheum.101248","article-title":"Clinical and serological hallmarks of systemic sclerosis overlap syndromes.","volume":"38","author":"Pakozdi","year":"2011","journal-title":"J Rheumatol"},{"key":"R7-1-20210226","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1093\/rheumatology\/keq205","article-title":"Usefulness of anti-cyclic citrullinated peptide antibody and rheumatoid factor to detect rheumatoid arthritis in patients with systemic sclerosis.","volume":"49","author":"Ueda-Hayakawa","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"R8-1-20210226","doi-asserted-by":"crossref","first-page":"3581","DOI":"10.1007\/s00296-011-2205-3","article-title":"Evaluating hand in systemic sclerosis.","volume":"32","author":"Arslan Tas","year":"2012","journal-title":"Rheumatol Int"},{"key":"R9-1-20210226","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1136\/ard.2004.022111","article-title":"Presence of rheumatoid factor and antibodies to citrullinated peptides in systemic lupus erythematosus.","volume":"64","author":"Hoffman","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"R10-1-20210226","first-page":"77","article-title":"Associations of erosive arthritis with anti-cyclic citrullinated peptide antibodies and MHC Class II alleles in systemic lupus erythematosus.","volume":"35","author":"Chan","year":"2008","journal-title":"J Rheumatol"},{"key":"R11-1-20210226","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1177\/0961203309102817","article-title":"The detecting and clinical value of anti-cyclic citrullinated peptide antibodies in patients with systemic lupus erythematosus.","volume":"18","author":"Qing","year":"2009","journal-title":"Lupus"},{"key":"R12-1-20210226","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.3899\/jrheum.090338","article-title":"Citrulline dependence of anti-cyclic citrullinated peptide antibodies in systemic lupus erythematosus as a marker of deformingerosive arthritis.","volume":"36","author":"Kakumanu","year":"2009","journal-title":"J Rheumatol"},{"key":"R13-1-20210226","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1191\/0961203302lu189oa","article-title":"Clinical and immunogenetic characterization of Mexican patients with rhupus.","volume":"11","author":"Simon","year":"2002","journal-title":"Lupus"},{"key":"R14-1-20210226","doi-asserted-by":"crossref","first-page":"R144","DOI":"10.1186\/ar2036","article-title":"Presence of antibodies against cyclic citrullinated peptides in patients with rhupus: a cross-sectional study.","volume":"8","author":"Amezcua-Guerra","year":"2006","journal-title":"Arthritis Res Ther"},{"key":"R15-1-20210226","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.3899\/jrheum.090183","article-title":"Destructive arthropathy associated with dermatomyositis sine myositis positive for anti-Jo-1 and anti-cyclic citrullinated peptide antibodies.","volume":"36","author":"Nagashima","year":"2009","journal-title":"J Rheumatol"},{"key":"R16-1-20210226","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.3899\/jrheum.091402","article-title":"Anticyclic citrullinated peptide antibodies as markers of erosive arthritis in antisynthetase syndrome.","volume":"37","author":"Cavagna","year":"2010","journal-title":"J Rheumatol"},{"key":"R17-1-20210226","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s10067-009-1370-1","article-title":"Etanercept-induced anti-Jo-1-antibody-positive polymyositis in a patient with rheumatoid arthritis: a case report and review of the literature.","volume":"29","author":"Ishikawa","year":"2010","journal-title":"Clin Rheumatol"},{"key":"R18-1-20210226","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s10067-010-1666-1","article-title":"A case of antisynthetase syndrome in a rheumatoid arthritis patient with anti-PL-12 antibody following treatment with etanercept.","volume":"30","author":"Ishikawa","year":"2011","journal-title":"Clin Rheumatol"},{"key":"R19-1-20210226","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s00296-009-1222-y","article-title":"Development of antisynthetase syndrome in a patient with rheumatoid arthritis.","volume":"31","author":"Park","year":"2011","journal-title":"Rheumatol Int"},{"key":"R20-1-20210226","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.resinv.2012.04.003","article-title":"A case of interstitial lung disease with anti-EJ and anti-CCP antibodies preceding rheumatoid arthritis.","volume":"50","author":"Tomioka","year":"2012","journal-title":"Respir Investig"},{"key":"R21-1-20210226","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1093\/rheumatology\/kep065","article-title":"Anti-cyclic citrullinated peptide and anti-keratin antibodies in patients with idiopathic inflammatory myopathy.","volume":"48","author":"Labrador-Horrillo","year":"2009","journal-title":"Rheumatology (Oxford)"},{"issue":"suppl 10","key":"R22-1-20210226","first-page":"881","article-title":"Distinct arthropathies inpatients with anti-aminoacyl tRNAsynthetase antibodies: utility ofautoantibody profiles in Discrimination.","volume":"65","author":"Kaneko","year":"2013","journal-title":"Arthritis Rheum"},{"key":"R23-1-20210226","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1093\/qjmed\/77.1.1019","article-title":"Polymyositis, pulmonary fibrosis and autoantibodies to aminoacyl-tRNA synthetase enzymes.","volume":"77","author":"Marguerie","year":"1990","journal-title":"Q J Med"},{"key":"R24-1-20210226","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1136\/annrheumdis-2012-201800","article-title":"Patients with non-Jo-1 anti-tRNA-synthetase autoantibodies have worse survival than Jo-1 positive patients.","volume":"73","author":"Aggarwal","year":"2014","journal-title":"Ann Rheum Dis Ann Rheum Dis"},{"key":"R25-1-20210226","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.autrev.2012.06.006","article-title":"Hierarchical cluster and survival analyses of antisynthetase syndrome: phenotype and outcome are correlated with anti-tRNA synthetase antibody specificity.","volume":"12","author":"Hervier","year":"2012","journal-title":"Autoimmun Rev"},{"key":"R26-1-20210226","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1002\/art.1780331106","article-title":"A subluxing arthropathy associated with the anti-Jo-1 antibody in polymyositisdermatomyositis.","volume":"33","author":"Oddis","year":"1990","journal-title":"Arthritis Rheum"},{"key":"R27-1-20210226","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1136\/ard.2007.078907","article-title":"Subluxing arthropathy: an unusual manifestation of the antisynthetase syndrome.","volume":"68","author":"Meyer","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"R28-1-20210226","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/RHU.0b013e3181f3bf9c","article-title":"Antisynthetase syndrome presenting as rheumatoid-like polyarthritis.","volume":"16","author":"Mumm","year":"2010","journal-title":"J Clin Rheumatol"},{"key":"R29-1-20210226","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1196\/annals.1398.047","article-title":"Clinical significance of anti-histidyl-tRNA synthetase (Jo1) autoantibodies.","volume":"1109","author":"Gomard-Mennesson","year":"2007","journal-title":"Ann N Y Acad Sci"},{"key":"R30-1-20210226","first-page":"1326","article-title":"How many joints in the hands and wrists should be included in a score of radiologic abnormalities used to assess rheumatoid arthritis Arthritis R","volume":"28","author":"Sharp","year":"1985","journal-title":"heum"},{"key":"R31-1-20210226","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1056\/NEJM197502132920706","article-title":"Polymyositis and dermatomyositis (first of two parts).","volume":"292","author":"Bohan","year":"1975","journal-title":"N Engl J Med"},{"key":"R32-1-20210226","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1164\/ajrccm.165.2.ats01","article-title":"This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001.","volume":"165","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"R33-1-20210226","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1378\/chest.09-0444","article-title":"Rheumatoid arthritis-associated interstitial lung disease: the relevance of histopathologic and radiographic pattern.","volume":"136","author":"Kim","year":"2009","journal-title":"Chest"},{"key":"R34-1-20210226","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1007\/s10067-011-1727-0","article-title":"The association of Raynauds syndrome with rheumatoid arthritis-a meta-analysis.","volume":"30","author":"Hartmann","year":"2011","journal-title":"Clin Rheumatol"},{"key":"R35-1-20210226","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1183\/09031936.00092309","article-title":"Usual interstitial pneumonia in rheumatoid arthritis-associated interstitial lung disease.","volume":"35","author":"Kim","year":"2010","journal-title":"Eur Respir J"},{"key":"R36-1-20210226","doi-asserted-by":"crossref","first-page":"3439","DOI":"10.1002\/art.30513","article-title":"Short-term and long-term outcomes of interstitial lung disease in polymyositis and dermatomyositis: a series of 107 patients.","volume":"63","author":"Marie","year":"2011","journal-title":"Arthritis Rheum"},{"key":"R37-1-20210226","first-page":"1261","article-title":"Dermatomyositis associated with thyroid cancer: a paraneoplastic syndrome Rheumatol I","volume":"29","author":"Nagashima","year":"2009","journal-title":"nt"},{"key":"R38-1-20210226","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1002\/art.24827","article-title":"Anti-citrullinated peptide antibody (ACPA) assays and their role in the diagnosis of rheumatoid arthritis.","volume":"61","author":"Aggarwal","year":"2009","journal-title":"Arthritis Rheum"},{"key":"R39-1-20210226","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1136\/ard.2009.126532","article-title":"EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs.","volume":"69","author":"Smolen","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"R40-1-20210226","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1136\/ard.2010.144998","article-title":"Updated consensus statement on the use of rituximab in patients with rheumatoid arthritis.","volume":"70","author":"Buch","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"R41-1-20210226","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1136\/ard.2005.045898","article-title":"Rituximab in the treatment of antisynthetase syndrome.","volume":"65","author":"Brulhart","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"R42-1-20210226","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1093\/rheumatology\/kep157","article-title":"Rituximab treatment of the anti-synthetase syndrome: a retrospective case series.","volume":"48","author":"Sem","year":"2009","journal-title":"Rheumatology (Oxford)"},{"key":"R43-1-20210226","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1002\/art.38270","article-title":"Predictors of clinical improvement in rituximab-treated refractory adult and juvenile dermatomyositis and adult polymyositis.","volume":"66","author":"Aggarwal","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"R44-1-20210226","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.rmed.2012.01.001","article-title":"Rituximab therapy for refractory interstitial lung disease related to antisynthetase syndrome.","volume":"106","author":"Marie","year":"2012","journal-title":"Respir Med"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000000523","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T22:41:11Z","timestamp":1620945671000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201505040-00001"}},"subtitle":["An Overlapping Rheumatoid Arthritis and Antisynthetase Syndrome"],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":44,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000000523","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2015,5]]}}}